FITOTERAPIA 润色咨询

FITOTERAPIA

出版年份：1947 年文章数：3827 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：6.1% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2110516, encodeId=a07621105164d, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：我投搞了，等了一个星期，还是显示只提交给杂志社，什么变化也没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74268368492, createdName=ms7000001656453510, createdTime=Tue Jan 17 04:11:00 CST 2023, time=2023-01-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2162042, encodeId=af332162042cd, content=审稿速度:3.0<br>偏重的研究方向：天然药物化学<br>经验分享：9.10 submitted to journal 10.8 with editor 10.9 decision in process 10.10 reject without review. 初审一个月的杂志，大家避坑吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Tue Oct 10 20:28:20 CST 2023, time=2023-10-10, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2150594, encodeId=938e21505940c, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：药代动力学;分析化学;中药<br>经验分享：我的论文内容比较杂，包括了单味中药分析化学+药代+细胞，6.12.投稿，7.21.返修，要求8.20.前重新提交，一共2个审稿人，每人都提了4~5个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93ff8547990, createdName=ms9000000747027888, createdTime=Mon Jul 31 10:45:04 CST 2023, time=2023-07-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆)]
    2024-05-28 ms2000001320609758

    请问with editor 多久啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2110516, encodeId=a07621105164d, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：我投搞了，等了一个星期，还是显示只提交给杂志社，什么变化也没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74268368492, createdName=ms7000001656453510, createdTime=Tue Jan 17 04:11:00 CST 2023, time=2023-01-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2162042, encodeId=af332162042cd, content=审稿速度:3.0<br>偏重的研究方向：天然药物化学<br>经验分享：9.10 submitted to journal 10.8 with editor 10.9 decision in process 10.10 reject without review. 初审一个月的杂志，大家避坑吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Tue Oct 10 20:28:20 CST 2023, time=2023-10-10, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2150594, encodeId=938e21505940c, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：药代动力学;分析化学;中药<br>经验分享：我的论文内容比较杂，包括了单味中药分析化学+药代+细胞，6.12.投稿，7.21.返修，要求8.20.前重新提交，一共2个审稿人，每人都提了4~5个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93ff8547990, createdName=ms9000000747027888, createdTime=Mon Jul 31 10:45:04 CST 2023, time=2023-07-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆)]
    2024-03-29 ms7000001891957838 来自江苏省

    审稿速度:6.0 | 投稿命中率:25.0
    偏重的研究方向：药代动
    经验分享：提交一直处于submit 状态

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2110516, encodeId=a07621105164d, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：我投搞了，等了一个星期，还是显示只提交给杂志社，什么变化也没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74268368492, createdName=ms7000001656453510, createdTime=Tue Jan 17 04:11:00 CST 2023, time=2023-01-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2162042, encodeId=af332162042cd, content=审稿速度:3.0<br>偏重的研究方向：天然药物化学<br>经验分享：9.10 submitted to journal 10.8 with editor 10.9 decision in process 10.10 reject without review. 初审一个月的杂志，大家避坑吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Tue Oct 10 20:28:20 CST 2023, time=2023-10-10, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2150594, encodeId=938e21505940c, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：药代动力学;分析化学;中药<br>经验分享：我的论文内容比较杂，包括了单味中药分析化学+药代+细胞，6.12.投稿，7.21.返修，要求8.20.前重新提交，一共2个审稿人，每人都提了4~5个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93ff8547990, createdName=ms9000000747027888, createdTime=Mon Jul 31 10:45:04 CST 2023, time=2023-07-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆)]
    2019-06-28 小十二小事儿

    中药提取物动物药理收吗

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2110516, encodeId=a07621105164d, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：我投搞了，等了一个星期，还是显示只提交给杂志社，什么变化也没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74268368492, createdName=ms7000001656453510, createdTime=Tue Jan 17 04:11:00 CST 2023, time=2023-01-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2162042, encodeId=af332162042cd, content=审稿速度:3.0<br>偏重的研究方向：天然药物化学<br>经验分享：9.10 submitted to journal 10.8 with editor 10.9 decision in process 10.10 reject without review. 初审一个月的杂志，大家避坑吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Tue Oct 10 20:28:20 CST 2023, time=2023-10-10, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2150594, encodeId=938e21505940c, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：药代动力学;分析化学;中药<br>经验分享：我的论文内容比较杂，包括了单味中药分析化学+药代+细胞，6.12.投稿，7.21.返修，要求8.20.前重新提交，一共2个审稿人，每人都提了4~5个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93ff8547990, createdName=ms9000000747027888, createdTime=Mon Jul 31 10:45:04 CST 2023, time=2023-07-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆)]
    2019-10-31 憨憨在奔跑

    请问各位，真的很快吗？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2110516, encodeId=a07621105164d, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：我投搞了，等了一个星期，还是显示只提交给杂志社，什么变化也没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74268368492, createdName=ms7000001656453510, createdTime=Tue Jan 17 04:11:00 CST 2023, time=2023-01-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2162042, encodeId=af332162042cd, content=审稿速度:3.0<br>偏重的研究方向：天然药物化学<br>经验分享：9.10 submitted to journal 10.8 with editor 10.9 decision in process 10.10 reject without review. 初审一个月的杂志，大家避坑吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Tue Oct 10 20:28:20 CST 2023, time=2023-10-10, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2150594, encodeId=938e21505940c, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：药代动力学;分析化学;中药<br>经验分享：我的论文内容比较杂，包括了单味中药分析化学+药代+细胞，6.12.投稿，7.21.返修，要求8.20.前重新提交，一共2个审稿人，每人都提了4~5个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93ff8547990, createdName=ms9000000747027888, createdTime=Mon Jul 31 10:45:04 CST 2023, time=2023-07-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆)]
    2023-10-05 ms1000001090708001 来自云南省

    审稿速度:2.0
    偏重的研究方向：天然化合物
    经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？

    17

    展开17条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2110516, encodeId=a07621105164d, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：我投搞了，等了一个星期，还是显示只提交给杂志社，什么变化也没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74268368492, createdName=ms7000001656453510, createdTime=Tue Jan 17 04:11:00 CST 2023, time=2023-01-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2162042, encodeId=af332162042cd, content=审稿速度:3.0<br>偏重的研究方向：天然药物化学<br>经验分享：9.10 submitted to journal 10.8 with editor 10.9 decision in process 10.10 reject without review. 初审一个月的杂志，大家避坑吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Tue Oct 10 20:28:20 CST 2023, time=2023-10-10, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2150594, encodeId=938e21505940c, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：药代动力学;分析化学;中药<br>经验分享：我的论文内容比较杂，包括了单味中药分析化学+药代+细胞，6.12.投稿，7.21.返修，要求8.20.前重新提交，一共2个审稿人，每人都提了4~5个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93ff8547990, createdName=ms9000000747027888, createdTime=Mon Jul 31 10:45:04 CST 2023, time=2023-07-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆)]
    2024-03-29 ms7000001891957838 来自江苏省

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享：好

    5

    展开5条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2110516, encodeId=a07621105164d, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：我投搞了，等了一个星期，还是显示只提交给杂志社，什么变化也没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74268368492, createdName=ms7000001656453510, createdTime=Tue Jan 17 04:11:00 CST 2023, time=2023-01-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2162042, encodeId=af332162042cd, content=审稿速度:3.0<br>偏重的研究方向：天然药物化学<br>经验分享：9.10 submitted to journal 10.8 with editor 10.9 decision in process 10.10 reject without review. 初审一个月的杂志，大家避坑吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Tue Oct 10 20:28:20 CST 2023, time=2023-10-10, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2150594, encodeId=938e21505940c, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：药代动力学;分析化学;中药<br>经验分享：我的论文内容比较杂，包括了单味中药分析化学+药代+细胞，6.12.投稿，7.21.返修，要求8.20.前重新提交，一共2个审稿人，每人都提了4~5个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93ff8547990, createdName=ms9000000747027888, createdTime=Mon Jul 31 10:45:04 CST 2023, time=2023-07-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆)]
    2023-01-17 ms7000001656453510 来自河北省

    审稿速度:24.0 | 投稿命中率:5.0
    经验分享：我投搞了，等了一个星期，还是显示只提交给杂志社，什么变化也没有

    13

    展开13条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2110516, encodeId=a07621105164d, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：我投搞了，等了一个星期，还是显示只提交给杂志社，什么变化也没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74268368492, createdName=ms7000001656453510, createdTime=Tue Jan 17 04:11:00 CST 2023, time=2023-01-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2162042, encodeId=af332162042cd, content=审稿速度:3.0<br>偏重的研究方向：天然药物化学<br>经验分享：9.10 submitted to journal 10.8 with editor 10.9 decision in process 10.10 reject without review. 初审一个月的杂志，大家避坑吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Tue Oct 10 20:28:20 CST 2023, time=2023-10-10, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2150594, encodeId=938e21505940c, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：药代动力学;分析化学;中药<br>经验分享：我的论文内容比较杂，包括了单味中药分析化学+药代+细胞，6.12.投稿，7.21.返修，要求8.20.前重新提交，一共2个审稿人，每人都提了4~5个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93ff8547990, createdName=ms9000000747027888, createdTime=Mon Jul 31 10:45:04 CST 2023, time=2023-07-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆)]
    2023-10-10 ms1000001090708001 来自贵州省

    审稿速度:3.0
    偏重的研究方向：天然药物化学
    经验分享：9.10 submitted to journal 10.8 with editor 10.9 decision in process 10.10 reject without review. 初审一个月的杂志，大家避坑吧

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2110516, encodeId=a07621105164d, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：我投搞了，等了一个星期，还是显示只提交给杂志社，什么变化也没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74268368492, createdName=ms7000001656453510, createdTime=Tue Jan 17 04:11:00 CST 2023, time=2023-01-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2162042, encodeId=af332162042cd, content=审稿速度:3.0<br>偏重的研究方向：天然药物化学<br>经验分享：9.10 submitted to journal 10.8 with editor 10.9 decision in process 10.10 reject without review. 初审一个月的杂志，大家避坑吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Tue Oct 10 20:28:20 CST 2023, time=2023-10-10, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2150594, encodeId=938e21505940c, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：药代动力学;分析化学;中药<br>经验分享：我的论文内容比较杂，包括了单味中药分析化学+药代+细胞，6.12.投稿，7.21.返修，要求8.20.前重新提交，一共2个审稿人，每人都提了4~5个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93ff8547990, createdName=ms9000000747027888, createdTime=Mon Jul 31 10:45:04 CST 2023, time=2023-07-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆)]
    2023-07-31 ms9000000747027888 来自上海

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：药代动力学;分析化学;中药
    经验分享：我的论文内容比较杂，包括了单味中药分析化学+药代+细胞，6.12.投稿，7.21.返修，要求8.20.前重新提交，一共2个审稿人，每人都提了4~5个意见

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2207093, encodeId=f384220e09333, content=请问with editor 多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a15e8252048, createdName=ms2000001320609758, createdTime=Tue May 28 19:15:19 CST 2024, time=2024-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2196016, encodeId=eaea21960166a, content=审稿速度:6.0 | 投稿命中率:25.0<br>偏重的研究方向：药代动<br>经验分享：提交一直处于submit 状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:05:59 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=573078, encodeId=0aa55e30786b, content=中药提取物动物药理收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=214, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=301f2289478, createdName=小十二小事儿, createdTime=Fri Jun 28 00:00:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579121, encodeId=5f9b5e912150, content=请问各位，真的很快吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/25/2cfa1fd22aea15203c674fdf7cc91dae.jpg, createdBy=3dab2048204, createdName=憨憨在奔跑, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2161047, encodeId=fa25216104edd, content=审稿速度:2.0<br>偏重的研究方向：天然化合物<br>经验分享：请问submitted 10天了，状态还是没变化，谁能告诉我是什么原因？要被拒稿了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Thu Oct 05 17:26:53 CST 2023, time=2023-10-05, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2196025, encodeId=a9f421960259b, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享：好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=458a9236206, createdName=ms7000001891957838, createdTime=Fri Mar 29 10:42:44 CST 2024, time=2024-03-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2110516, encodeId=a07621105164d, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享：我投搞了，等了一个星期，还是显示只提交给杂志社，什么变化也没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74268368492, createdName=ms7000001656453510, createdTime=Tue Jan 17 04:11:00 CST 2023, time=2023-01-17, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2162042, encodeId=af332162042cd, content=审稿速度:3.0<br>偏重的研究方向：天然药物化学<br>经验分享：9.10 submitted to journal 10.8 with editor 10.9 decision in process 10.10 reject without review. 初审一个月的杂志，大家避坑吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81d08622119, createdName=ms1000001090708001, createdTime=Tue Oct 10 20:28:20 CST 2023, time=2023-10-10, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2150594, encodeId=938e21505940c, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：药代动力学;分析化学;中药<br>经验分享：我的论文内容比较杂，包括了单味中药分析化学+药代+细胞，6.12.投稿，7.21.返修，要求8.20.前重新提交，一共2个审稿人，每人都提了4~5个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93ff8547990, createdName=ms9000000747027888, createdTime=Mon Jul 31 10:45:04 CST 2023, time=2023-07-31, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2102415, encodeId=bf5021024156e, content=偏重的研究方向：药理学;药理<br>经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07528164113, createdName=ms9000000732799769, createdTime=Thu Nov 24 14:56:00 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆)]
    2022-11-24 ms9000000732799769 来自重庆

    偏重的研究方向：药理学;药理
    经验分享：投了欧洲药理学杂志，让转投这个，请问这个期刊怎么样呢，审稿流程快吗，赶着毕业…

    1

    展开1条回复
共138条页码: 1/14页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分